Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

David Walt

OTHER INVESTOR TYPE
Active STATUS
1 PROFESSIONALS
7 INVESTMENTS
3 PORTFOLIO
Description

Dr. David Walt is a Co-Founder and Board Member of Arbor Biotechnologies and Sherlock Biosciences. He is the Scientific Founder, Board Member and Chairman of the Scientific Advisory Board at Quanterix. He also serves as its Advisor at Illumina Ventures. David is an internationally-recognized expert in nanoscience and diagnostics and has invented numerous transformative technologies that have led to major commercial successes. David has had a highly successful academic career combined with significant entrepreneurial activity. He is a University Professor, Professor of Chemistry, Professor of Genetics, Professor of Biomedical Engineering and Professor of Neuroscience at Tufts University and is a Howard Hughes Medical Institute Professor. He also is the Founding Director of the Tufts Institute for Innovation. His laboratory pioneered the development of microwell arrays, which revolutionized the field of genetic analysis. Dr. Walt's laboratory also introduced the idea of digital protein detection by developing a high throughput technology for performing single molecule analysis. He received a B.S. in chemistry from the University of Michigan and a Ph.D. in chemical biology from SUNY at Stony Brook. He completed his postdoctoral studies at MIT.

Investor Status
Actively Seeking New Investments
Primary Investor Type
Angel (individual)
Primary Office
  • Boston, MA
  • United States

David Walt Investments (7)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
NextGen Jane 01-Apr-2019 Early Stage VC 000 Other Healthcare Technology Systems Generating Revenue 00000 0000 00.0
0000000 18-Dec-2017 0000 00000 000 Other Healthcare Technology Systems Generating Revenue 00000 0000 00.0
0000000 06-Nov-2017 00000 00000 000.00 Drug Delivery Generating Revenue/Not Profitable 00000 0000 00.0
0000000 27-Sep-2017 0000 0000 Drug Delivery Generating Revenue/Not Profitable 00000 0000 00.0
0000000 21-Oct-2015 00000 00000 0000 Drug Delivery Generating Revenue/Not Profitable 00000 0000 00.0
908 Devices 06-May-2015 Later Stage VC 0000 Other Commercial Products Generating Revenue 00000 0000 00.0
Exicure 05-Feb-2015 Later Stage VC 0000 Drug Delivery Generating Revenue/Not Profitable 00000 0000 00.0
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore David Walt’s full profile, request a free trial.

David Walt Team (1)

Name Title Deals Funds Boards Office Contact
Info
David Walt Ph.D Angel Investor 0 0 Boston, MA